NCT07362615Not yet recruiting
An AI-Assisted Art Therapy Co-Creation Intervention
An AI-Assisted Art Therapy Co-Creation Intervention for Symptom Burden, Anxiety, and Emotional Regulation in Pediatric Chemotherapy Patients: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 23 Jan 2026
Brief summary (registry, in English)
This randomized controlled trial aims to evaluate the effects of an AI-assisted interactive art therapy co-creation intervention on symptom burden, state anxiety, and emotional regulation in pediatric patients receiving chemotherapy. The study will be conducted as a parallel-group randomized controlled trial at the Pediatric Hematology-Oncology units of Gazi University Health Application and Research Center between February 2026 and May 2027. A total of 60 children aged 10-18 years who are undergoing a new chemotherapy cycle will be randomly assigned to either an intervention group receiving a four-day AI-assisted art-based program or a control group receiving standard care. Outcome measures will be assessed before and after the intervention period. The study aims to provide evidence on the feasibility and effectiveness of a short-term, technology-assisted psychosocial intervention to support emotional well-being in children undergoing chemotherapy.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 15 Jan 2026
- Start date
- 20 Jan 2026
- Primary completion date
- 20 May 2027
- Lead sponsor
- Gazi University
- Diseases
- Childhood cancers
- NCT number
- NCT07362615
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 20 Jan 2026 to the primary completion date, 20 May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Severe neurocognitive impairment, severe physical instability, or being under sedation
- Experiencing a severe traumatic life event unrelated to the disease within the last 6 months
- Being in the terminal phase clinically
- Being under clinical observation due to a psychiatric diagnosis
- Having fatigue, pain, or medical complications that would prevent participation in the intervention
Who the study is looking for
- Be between 10 and 18 years of age
- Have been receiving chemotherapy treatment for at least 6 months
- Be between days 1 and 4 of a new chemotherapy cycle
- Be able to communicate in Turkish
- Be clinically stable
- The participant and their parent/guardian must consent to participate in the study and provide written consent
Age in the registry: 10 years to 18 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.